PD-1 and LAG-3-positive T cells are associated with clinical outcomes of relapsed/refractory multiple myeloma patients

PD-1 and LAG-3-positive T cells are associated with clinical outcomes of relapsed/refractory multiple myeloma patients

Abstract Objective To investigate the frequency of PD-1 and LAG-3-positive T cells in relapsed/refractory multiple myeloma (RRMM) patients and its clinical significance. Methods This prospective observational study enrolled a total of 71 RRMM patients, as well as 70 MM patients (non-refractory) and...

Full description

Bibliographic Details
Main Authors: Ming Chen, Jinlian Zhu, Xuedong Yang, Jianxin Yao, Yuqing Liu, Qiang Liu
Format: Article
Language:English
Published: BMC 2022-12-01
Series:European Journal of Medical Research
Subjects:
Relapsed/refractory multiple myeloma
T cell subtype
PD-1
LAG-3
Online Access:https://doi.org/10.1186/s40001-022-00923-5

Internet

https://doi.org/10.1186/s40001-022-00923-5

Similar Items